1. Home
  2. STVN vs GTES Comparison

STVN vs GTES Comparison

Compare STVN & GTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • GTES
  • Stock Information
  • Founded
  • STVN 1949
  • GTES 1911
  • Country
  • STVN Italy
  • GTES United States
  • Employees
  • STVN N/A
  • GTES N/A
  • Industry
  • STVN Containers/Packaging
  • GTES Industrial Machinery/Components
  • Sector
  • STVN Consumer Discretionary
  • GTES Industrials
  • Exchange
  • STVN Nasdaq
  • GTES Nasdaq
  • Market Cap
  • STVN 5.7B
  • GTES 4.9B
  • IPO Year
  • STVN 2021
  • GTES 2018
  • Fundamental
  • Price
  • STVN $20.93
  • GTES $19.24
  • Analyst Decision
  • STVN Buy
  • GTES Buy
  • Analyst Count
  • STVN 7
  • GTES 9
  • Target Price
  • STVN $26.93
  • GTES $24.00
  • AVG Volume (30 Days)
  • STVN 372.3K
  • GTES 2.8M
  • Earning Date
  • STVN 03-06-2025
  • GTES 04-30-2025
  • Dividend Yield
  • STVN 0.28%
  • GTES N/A
  • EPS Growth
  • STVN N/A
  • GTES N/A
  • EPS
  • STVN 0.45
  • GTES 0.74
  • Revenue
  • STVN $1,143,012,735.00
  • GTES $3,408,200,000.00
  • Revenue This Year
  • STVN $8.60
  • GTES $1.20
  • Revenue Next Year
  • STVN $12.43
  • GTES $4.49
  • P/E Ratio
  • STVN $46.99
  • GTES $25.50
  • Revenue Growth
  • STVN 1.72
  • GTES N/A
  • 52 Week Low
  • STVN $16.56
  • GTES $15.14
  • 52 Week High
  • STVN $31.61
  • GTES $23.85
  • Technical
  • Relative Strength Index (RSI)
  • STVN 50.35
  • GTES 45.24
  • Support Level
  • STVN $20.11
  • GTES $17.72
  • Resistance Level
  • STVN $21.21
  • GTES $20.41
  • Average True Range (ATR)
  • STVN 1.00
  • GTES 0.60
  • MACD
  • STVN -0.05
  • GTES -0.02
  • Stochastic Oscillator
  • STVN 35.51
  • GTES 56.55

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About GTES Gates Industrial Corporation plc

Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.

Share on Social Networks: